Closed · CDC-RFA-GH21-2169 · CFDA 93.318 · Discretionary
Strengthening detection, prevention and response to infectious disease threats in Uzbekistan
Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.
- Varies
- Award range
- Closed
- Status
- July 10, 2021
- Close date
- 1
- Expected awards
The verdict
Strengthening detection, prevention and response to infectious disease threats in Uzbekistan is a closed discretionary listing from Centers for Disease Control - CGH that offered Varies by applicant across 1 expected award. Future funding cycles may be published under the same CFDA number.
- Varies
- award range
- Closed
- application status
- 1
- expected award
- 93.318
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Strengthening detection, prevention and response to infectious disease threats in Uzbekistan - is cataloged under number CDC-RFA-GH21-2169 and tied to CFDA assistance listing 93.318, posted by Centers for Disease Control - CGH. Grants.gov currently shows the opportunity as closed, first posted on May 11, 2021. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Varies by applicant. The agency has projected $207.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $207.0 million estimated pool, the average award works out to roughly $207.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 10, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Varies by applicant
Close Date
July 10, 2021
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Posted
May 11, 2021
Est. Total Funding
$207,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
Currently the Research Institute for Epidemiology, Microbiology and Infectious Diseases of the Ministry of Health of the Republic of Uzbekistan (RIEMID) is concluding activities under CDC Co-Ag GH001653 focused on antimicrobial resistance. RIEMID is designated to be the Center of genetic technologies by the Presidential Decree PP-4790 dated July 27, 2020. In this regard, CDC would like to work with RIEMID on non-research activities, including establishing a Center for Genome Sequencing of Emerging, Re-Emerging Infectious Diseases by 1) providing training and mentorship to the staff at the Center, 2) purchasing specialized gene sequencing equipment, 3) sharing established methodologies for sequencing of pathogens, 4) analyzing sequencing data, and 5) showing the relevance of sharing data with the global community. This Center would increase the capacity of Uzbekistan to detect, investigate, and report COVID-19 transmission. Uzbekistan will have the ability to recognize new strains or mutations of strain of SARS-CoV-2. Sequencing data would give the country (and others if shared) a deeper understanding of pathogen phylogeny, which can assist in vaccine production. In addition, CDC would like RIEMID to continue working on AMR surveillance, particularly extend it to the whole country, conduct non-research activities on strengthening the rational use of antimicrobials in the country, introduce genetic surveillance and new systems of rapid identification of bacteria (MALDI-TOF), improve quality of AMR data by assisting implementation of QMS in the bacteriology laboratories and consolidating the AMR data in RIEMID AMR reference center.
Eligibility
Grants.gov lists this opportunity under eligibility category code 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Shana Eatman wrf3@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |